<code id='9E185544B6'></code><style id='9E185544B6'></style>
    • <acronym id='9E185544B6'></acronym>
      <center id='9E185544B6'><center id='9E185544B6'><tfoot id='9E185544B6'></tfoot></center><abbr id='9E185544B6'><dir id='9E185544B6'><tfoot id='9E185544B6'></tfoot><noframes id='9E185544B6'>

    • <optgroup id='9E185544B6'><strike id='9E185544B6'><sup id='9E185544B6'></sup></strike><code id='9E185544B6'></code></optgroup>
        1. <b id='9E185544B6'><label id='9E185544B6'><select id='9E185544B6'><dt id='9E185544B6'><span id='9E185544B6'></span></dt></select></label></b><u id='9E185544B6'></u>
          <i id='9E185544B6'><strike id='9E185544B6'><tt id='9E185544B6'><pre id='9E185544B6'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:911
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          It shouldn't be easy to buy synthetic DNA to recreate a deadly virus
          It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

          AdobeItshouldbehard—exceedinglyhard—toobtainthesyntheticDNAneededtorecreatethevirusthatcausedthedead

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Innovation in antibiotics is ailing. 'Brain drain' may kill it

          Asantibioticsresearchshrivels,thebraindrainawayfromthisfieldwillhavemanylabslookingthisempty.AdobeIn